KRAS and Patent ductus arteriosus: A multivariate analysis of factors influencing outcomes (n = 77, 35 R-PDA, 36 mPDA, and 6 LA-PDA) demonstrated that mut-KRAS concentrations >0.165 copies/L are associated with poorer OS [71].